Graf Akcie CCXI (ChemoCentryx Inc). Diskuze k akciím CCXI. Aktuální informace CCXI.

Základní informace o společnosti ChemoCentryx Inc (Akcie CCXI)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.4B
Hodnota podniku (EV) N/A
Tržby 21.609M
EBITDA N/A
Zisk -122.86
Růst v tržbách Q/Q -96.33 %
Růst v tržbách Y/Y -71.60 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.05
EV/Sales 122.32
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 111.26
P/FCF N/A
Price/Book 6.23
Účetní hodnota na akcii 5.53
Hotovost na akcii 6.26
FCF vůči ceně -4.25 %
Počet zaměstnanců 133
Tržba na zaměstnance 162.474k
Profit margin -85.31 %
Operating margin -562.29 %
Gross margin 100.00 %
EBIT margin -555.66 %
EBITDA margin -80.28 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -293.10 %
EPS - Očekávaný růst příští rok 40.00 %
Return on assets -24.34 %
Return on equity -33.17 %
ROIC -14.48 %
ROCE -29.12 %
Dluhy/Equity 0.35
Čistý dluh/EBITDA 20.79
Current ratio 5.73
Quick Ratio 5.73
Volatilita 9.07
Beta 0.00
RSI 70.03
Cílová cena analytiků 77
Známka akcie (dle analytiků) 1.29
Insider ownership 23.74 %
Institutional ownership 72.45 %
Počet akcií 69.9M
Procento shortovaných akcií 6.66 %
Short ratio 0.53 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2012
Země United States

Finanční výsledky akcie CCXI

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$36.128$42.875$82.497$11.935--
Cost Of Goods Sold------
Gross Profit$36.128$42.875$82.497$11.935--
Research And Development Expenses$70.276$62.736$49.495$37.945$33.183$33.815
SG&A Expenses$24.155$20.409$16.509$14.71$14.506$13.584
Other Operating Income Or Expenses------
Operating Expenses$94.431$83.145$66.004$52.655$47.689$47.399
Operating Income$-58.303$-40.27$16.493$-40.72$-47.689$-47.399
Total Non-Operating Income/Expense$2.814$2.304$1.366$0.757$0.384$0.47
Pre-Tax Income$-55.489$-37.966$17.859$-39.963$-47.305$-46.929
Income Taxes----$-47.305-
Income After Taxes$-55.489$-37.966$17.859$-39.963-$-46.929
Other Income------
Income From Continuous Operations$-55.489$-37.966$17.859$-39.963-$-46.929
Income From Discontinued Operations------
Net Income$-55.489$-37.966$17.859$-39.963$-47.305$-46.929
EBITDA$-56.661$-39.758$16.911$-40.372$-47.212$-46.856
EBIT$-58.303$-40.27$16.493$-40.72$-47.689$-47.399
Basic Shares Outstanding575048464443
Shares Outstanding575050464443
Basic EPS$-0.98$-0.76$0.37$-0.86$-1.08$-1.08
EPS - Earnings Per Share$-0.98$-0.76$0.36$-0.86$-1.08$-1.08
# 2020 2019 2018 2017 2016 2015
Current Ratio2.95132.81675.45983.878713.11169.0756
Long-term Debt / Capital0.23060.57190.0557---
Debt/Equity Ratio0.29981.33590.059---
Gross Margin100100100100--
Operating Margin-161.379-93.924219.9923-341.1814--
EBIT Margin-161.379-93.924219.9923-341.1814--
EBITDA Margin-156.8341-92.7320.4989-338.2656--
Pre-Tax Profit Margin-153.59-88.550421.6481-334.8387--
Net Profit Margin-153.59-88.550421.6481-334.8387--
Asset Turnover0.17280.23390.43570.0766--
Inventory Turnover Ratio------
Receiveable Turnover205.272720.83331.61470.3951--
Days Sales In Receivables1.778117.52226.0428923.739--
ROE - Return On Equity-84.0742-257.606222.5302-80.1038--43.2103
Return On Tangible Equity-84.0742-257.606422.5302-80.1038--43.2103
ROA - Return On Assets-26.5392-20.71149.4328-25.6384--40.1168
ROI - Return On Investment-64.6831-110.279721.2752-80.1038--43.2103
Book Value Per Share1.09570.2911.62311.03811.6412.4998
Operating Cash Flow Per Share-1.56230.2316-0.74481.7391-0.1030.0213
Free Cash Flow Per Share-1.55940.2294-0.75281.7375-0.09990.0267

Porovnání s konkurencí: Akcie CCXI

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
CCXI 0.00 N/A -71.60 % 40.00 % -33.17 % 6.23 -85.31 %
Akcie ABBV 30.30 1.28 48.31 % 14.49 % 48.79 % 14.98 10.08 %
Akcie AMGN 21.11 1.66 4.87 % -2.29 % 60.57 % 12.77 28.57 %
Akcie BIIB 22.44 6.24 -19.26 % -53.28 % 17.89 % 4.05 29.76 %
Akcie BMY N/A 14.08 27.31 % 18.40 % -12.51 % 3.48 -21.20 %
Akcie GSK 16.47 3.36 N/A % -14.00 % 29.69 % 4.91 16.86 %
Akcie JNJ 23.88 1.67 10.79 % 7.27 % 27.01 % 6.71 17.82 %
Akcie MRK 35.60 1.38 2.87 % 13.14 % 19.42 % 7.90 14.72 %
Akcie PFE 17.66 1.97 4.96 % 50.00 % 19.81 % 3.72 22.95 %
Akcie TEVA N/A 0.79 -0.96 % 12.07 % -39.21 % 1.08 -23.95 %

Nedávné obchody insiderů: Akcie CCXI

Jméno Obchod Cena Objem
Thomas A. Edwards
Director
Prodej
24 Dec 2020
$61.32 $1,533,000
Markus J. Cappel
Chief Bus. Officer and Treasurer
Option
1 Jan 2021
$61.92 $1,306,512
Susan M Kanaya
EVP, CFO, and Sec.
Option
1 Jan 2021
$61.92 $1,878,219
Thomas J. Schall
President and CEO
Option
1 Jan 2021
$61.92 $5,442,706
Pui San Kwan
Principal Acctg Officer
Option
25 Jan 2021
$9.70 $40,585
Markus J. Cappel
Chief Bus. Officer and Treasurer
Option
25 Jan 2021
$11.02 $15,153
Thomas A. Edwards
Director
Prodej
2 Feb 2021
$60.94 $1,218,800
Pui San Kwan
Principal Acctg Officer
Option
4 Feb 2021
$10.46 $35,010
Markus J. Cappel
Chief Bus. Officer and Treasurer
Option
4 Feb 2021
$11.02 $106,068
Thomas A. Edwards
Director
Prodej
9 Feb 2021
$70.04 $28,016
Markus J. Cappel
Chief Bus. Officer and Treasurer
Option
9 Feb 2021
$11.02 $7,714

Diskuze k akciím CCXI